These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15923752)

  • 1. Numerical modeling of coronary drug eluting stents.
    Mongrain R; Leask R; Brunette J; Faik I; Bulman-Feleming N; Nguyen T
    Stud Health Technol Inform; 2005; 113():443-58. PubMed ID: 15923752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents.
    Mongrain R; Faik I; Leask RL; Rodés-Cabau J; Larose E; Bertrand OF
    J Biomech Eng; 2007 Oct; 129(5):733-42. PubMed ID: 17887899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach.
    O'Connell BM; Cunnane EM; Denny WJ; Carroll GT; Walsh MT
    Biomech Model Mechanobiol; 2014 Aug; 13(4):771-81. PubMed ID: 24101254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
    Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
    JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose model for stent-based delivery of a radioactive compound for the treatment of restenosis in coronary arteries.
    Janicki C; Hwang CW; Edelman ER
    Med Phys; 2003 Oct; 30(10):2622-8. PubMed ID: 14596298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical modelling of the physical factors that affect mass transport in the vasculature at early time periods.
    Denny WJ; Walsh MT
    Med Eng Phys; 2014 Mar; 36(3):308-17. PubMed ID: 24462324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.
    Zhu X; Pack DW; Braatz RD
    Comput Methods Biomech Biomed Engin; 2014; 17(3):187-98. PubMed ID: 22512464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).
    Guagliumi G; Sirbu V; Musumeci G; Bezerra HG; Aprile A; Kyono H; Fiocca L; Matiashvili A; Lortkipanidze N; Vassileva A; Popma JJ; Allocco DJ; Dawkins KD; Valsecchi O; Costa MA
    Circ Cardiovasc Interv; 2010 Aug; 3(4):367-75. PubMed ID: 20647562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin.
    Lambert TL; Dev V; Rechavia E; Forrester JS; Litvack F; Eigler NL
    Circulation; 1994 Aug; 90(2):1003-11. PubMed ID: 8044913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents.
    Balakrishnan B; Tzafriri AR; Seifert P; Groothuis A; Rogers C; Edelman ER
    Circulation; 2005 Jun; 111(22):2958-65. PubMed ID: 15927969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luminal flow patterns dictate arterial drug deposition in stent-based delivery.
    Kolachalama VB; Tzafriri AR; Arifin DY; Edelman ER
    J Control Release; 2009 Jan; 133(1):24-30. PubMed ID: 18926864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial.
    von Birgelen C; Zocca P; Buiten RA; Jessurun GAJ; Schotborgh CE; Roguin A; Danse PW; Benit E; Aminian A; van Houwelingen KG; Anthonio RL; Stoel MG; Somi S; Hartmann M; Linssen GCM; Doggen CJM; Kok MM
    Lancet; 2018 Oct; 392(10154):1235-1245. PubMed ID: 30253879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
    Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug deposition in coronary arteries with overlapping drug-eluting stents.
    Rikhtegar F; Edelman ER; Olgac U; Poulikakos D; Kurtcuoglu V
    J Control Release; 2016 Sep; 238():1-9. PubMed ID: 27432751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
    Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
    Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.
    Barlis P; Regar E; Serruys PW; Dimopoulos K; van der Giessen WJ; van Geuns RJ; Ferrante G; Wandel S; Windecker S; van Es GA; Eerdmans P; Jüni P; di Mario C
    Eur Heart J; 2010 Jan; 31(2):165-76. PubMed ID: 19889649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial.
    Teeuwen K; Spoormans EM; Bennett J; Dubois C; Desmet W; Ughi GJ; Belmans A; Kelder JC; Tijssen JGP; Agostoni P; Suttorp MJ; Adriaenssens T
    EuroIntervention; 2017 Aug; 13(5):e522-e530. PubMed ID: 28512069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.